Blood marker may predict IBD Flare-Ups
NCT ID NCT04535882
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking at whether a substance in the blood called LRG can help doctors tell how active ulcerative colitis or Crohn's disease is in the gut. Researchers will measure LRG levels in 300 people who might have these conditions and compare them with what is seen during a colonoscopy. The goal is to see if LRG could be a simple blood test to monitor disease activity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Showa Inan General Hospital
RECRUITINGKomagane, Nagano, 399-4117, Japan
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a probiotic enema heal the gut lining in ulcerative colitis?
- Amniotic cell secretions may fight gut inflammation and scarring — a lab study puts them to the test
- Could a diet change calm IBD by reshaping gut bacteria?
- Experimental drug aims to quiet gut inflammation in ulcerative colitis
- Two-Drug cocktail aims to tame stubborn Crohn's disease
- Medical records reveal clues to treating stubborn inflammatory bowel disease